Recent Finacing
Recent Raise
Agenus is an immuno-oncology company developing the BOT/BAL immunotherapy platform (botensilimab + balstilimab) to enhance and sustain anti-tumor immune responses, with advanced clinical trials across nine cancer types.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at Agenus.
